Stay updated on KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- ChecktodayChange DetectedThe study record’s October 2026 update shows that recruitment has closed and the study is no longer looking for participants. The latest version also includes changes to the study status, design, and outcome measures.SummaryDifference2%

- Check7 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check14 days agoChange DetectedThe site footer now identifies the website as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check28 days agoChange DetectedThe record history shows updates to the study's status and design, including changes to the arms/interventions and study description across versions, reflecting ongoing refinements to the trial details in the registry.SummaryDifference0.1%

- Check35 days agoChange DetectedFind contact information was added (lowercase 'c') and Find Contact Information was removed; the revision label changed from v3.6.6 to v3.7.0, reflecting a newer version in the history entries.SummaryDifference0.2%

- Check56 days agoChange DetectedThe record history now includes a new revision entry v3.6.6 and the v3.6.5 entry is removed from the list. This updates the visible revision history to reflect the latest changes to the study record.SummaryDifference0.1%

Stay in the know with updates to KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.